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Abstract:  The  marine  environment  is  an  untapped  source  of  bioactive  compounds. 
Specifically,  marine  macroalgae  (seaweeds)  are  rich  in  polysaccharides  that  could 
potentially be  exploited  as  prebiotic  functional  ingredients  for  both human  and  animal 
health applications. Prebiotics are non-digestible, selectively fermented compounds that 
stimulate the growth and/or activity of beneficial gut microbiota which, in turn, confer 
health  benefits  on  the  host.  This  review  will  introduce  the  concept  and  potential 
applications  of  prebiotics,  followed  by  an  outline  of  the  chemistry  of  seaweed 
polysaccharides. Their potential for use as prebiotics for both humans and animals will be 
highlighted by reviewing data from both in vitro and in vivo studies conducted to date.  
Keywords: marine macroalgae; polysaccharides; prebiotics; human and animal health 
Abbreviations:  GIT:  Gastrointestinal  tract;  SCFA:  short-chain  fatty  acids;  
NAOS:  Neoagaro-oligosaccharides;  FOS:  Fructo-oligosaccharides;  FISH:  Fluorescence 
in situ hybridization; PCR: Polymerase chain reaction; DGGE: Denaturing gradient gel 
electrophoresis; qPCR: Quantitative PCR 
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1. Introduction  
Marine macroalgae, or seaweeds as they are more commonly known, are one of nature’s most 
biologically  active  resources,  as  they  possess  a  wealth  of  bioactive  compounds.  For  example, 
compounds isolated from marine macroalgae have demonstrated various biological activities, such as 
antibacterial activity [1], antioxidant potential [2,3], anti-inflammatory properties [4], anti-coagulant 
activity [5], anti-viral activity [6] and apoptotic activity [7]. As a result, seaweed-derived compounds 
have important applications in a range of products in food, pharmaceuticals and cosmetics [8–10]. In 
addition to bioactive components, macroalgae are a rich source of dietary fiber (25–75% dry weight), 
of  which  water-soluble  fiber  constitutes  approximately  50–85%  [11].  Seaweeds  are  commonly 
classified into three main groups based on their pigmentation. Phaeophyta, or brown seaweeds, are 
predominantly  brown  due  to  the  presence  of  the  carotenoid  fucoxanthin  and  the  primary 
polysaccharides present include alginates, laminarins, fucans and cellulose [12,13]. Chlorophyta, or 
green seaweeds, are dominated by chlorophyll a and b, with ulvan being the major polysaccharide 
component [14]. The principal pigments found in rhodophyta, or red seaweeds, are phycoerythrin and 
phycocyanin and the primary polysaccharides are agars and carrageenans [15]. 
In the past decade, considerable research has been conducted on dietary modulation of intestinal 
microbiota.  One  particular  area  of  research  has  focused  on  the  concept  of  dietary  ―prebiotics‖  as 
functional ingredients for gut health, both for humans and animals. This review will examine evidence 
that  polysaccharides  from  marine  macroalgae,  such  as  fucoidan,  laminarin,  alginate  and  their 
derivatives, may offer potential for use as prebiotics, with particular emphasis on their use in human 
and  animal  health  applications.  First  the  concept  of  prebiotics  will  be  introduced,  followed  by  a 
summary of the chemistry of seaweed polysaccharides, and a discussion of data from both in vitro and 
in vivo studies that have examined the prebiotic potential of seaweed polysaccharides.  
2. The Prebiotic Concept 
The  gastrointestinal  tract  (GIT)  of  both  humans  and  animals  is  a  complex,  diverse,  microbial 
ecosystem. The colon is the most heavily colonized region of the GIT with up to 10
12 bacteria per 
gram  of  intestinal  contents.  The  dominant  genera  include  Bacteroides,  Prevotella,  Eubacterium, 
Clostridium and Bifidobacterium, with Lactobacillus, Staphylococcus, Enterococcus, Streptococcus, 
Enterobacter and Escherichia part of the sub-dominant flora (Figure 1) [16]. Potentially pathogenic 
and  beneficial  bacteria  co-exist  (Figure  1);  however,  strategies  are  being  sought  to  influence  this 
composition towards a more favorable balance, by reducing the amount of  potentially  harmful or 
pathogenic species and promoting the growth of species thought to have beneficial effects on host 
health  [17].  Dietary  modulation  of  the  intestinal  microflora  can  either  be  achieved  via  oral 
administration of probiotic micro-organisms or prebiotic compounds. The prebiotic concept was first 
proposed by Gibson and Roberfroid in 1995 [17] and the most recent definition of a prebiotic is ―a 
selectively fermented ingredient that allows specific changes, both in the composition and/or activity 
of the gastrointestinal microflora that confers benefits upon the host wellbeing and health‖ [18]. To be 
considered prebiotic, a compound must satisfy a number of criteria; firstly it must be resistant to 
digestion in the upper GIT and therefore resistant to acid and enzymatic hydrolysis; secondly, it must Mar. Drugs 2010, 8  
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be a selective substrate for the growth of beneficial bacteria and therefore result in a shift in the profile 
of the microflora and finally, it must induce luminal or systemic effects that are beneficial to host 
health [18]. In theory, any carbohydrate that enters the colon can potentially be considered prebiotic. 
However, while many naturally occurring carbohydrates from sources such as fruits and vegetables 
(i.e., chicory, artichoke, garlic, bananas) and milk have been investigated both in vitro and in vivo [19]; 
evidence that the compound satisfies the prebiotic criteria outlined above must ultimately be obtained 
in well-controlled human/animal studies. To date, only three carbohydrates types are accepted as true 
prebiotics; inulin and oligofructose, galactooligosaccharides and lactulose [20]. Many polysaccharides 
from various sources have displayed prebiotic activity both in vitro and in vivo. As seaweeds are rich 
in polysaccharides, they are an obvious choice for investigation as a source of prebiotics. 
Figure 1. Distribution of the dominant, sub-dominant and minor components of human 
fecal microflora. Major dominant phyla are denoted. *: Other components are at the family 
or genus level (adapted from reference [16]).  
 
Applications of prebiotics 
There are numerous purported health benefits attributed to the consumption of prebiotics by both 
humans and animals (Figure 2). The most notable and direct effects of prebiotics in vivo are mediated 
via modulation of intestinal microbiota (Figure 2) populations. A number of health effects in humans 
can  be  attributed  to  modulation  of  gut  microflora  and  these  have  been  extensively  studied  and Mar. Drugs 2010, 8  
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reviewed  [21–26].  Prebiotics  can  be  consumed  as  dietary  supplements  or  in  functional  foods.  A 
functional food is defined as a food which provides a health benefit beyond basic nutrition [27]. At 
present, there are a number of functional foods on the market which contain prebiotic compounds; for 
example, infant formula, soy milk, breakfast cereals and yogurts [28]. 
Figure 2. Mode of action of prebiotics and purported health benefits in humans and animals. 
 
Prebiotic  compounds  may  also  be  added  to  animal  feed,  as  an  alternative  to  antibiotics. 
Sub-therapeutic doses of antibiotics were used in-feed in Europe and continue to be used in the US as a 
management  tool  to  promote  growth  and  maintain  health  in  farm  animals,  in  particular  pigs  and 
poultry. However, due to concerns over increasing bacterial antibiotic resistance, in-feed antibiotics 
are no longer permitted for use as growth promoters in the EU since 2006. Consequences, including 
increased  enteric  infections,  reduced  pig  performance  and  increased  mortality  have  been  seen  in 
Nordic countries where the antibiotic ban has been in place since the late 1990s [29]. Therefore, one of 
the challenges facing the livestock industry is maintaining the growth performance targets required for 
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cost-effective animal production without the use of antibiotic growth promoters. Although the exact 
mode of action of antibiotic growth promoters is unknown, they most likely act via modulation of 
intestinal  microbial  populations,  including  reduction  of  pathogenic  microorganisms.  Prebiotic 
compounds  therefore  offer  potential  as  an  alternative  to  in-feed  antibiotic  growth  promoters  [30]. 
Apart from improving animal performance and health, prebiotics may also reduce carriage of enteric 
pathogens, thereby preventing transmission to humans (Figure 2) [30]. 
Dietary  prebiotics  sourced  from  seaweeds  may  provide  a  means  to  modulate  the  intestinal 
microbiota  thereby  improving  the  overall  health  of  animals  and  humans.  In  particular,  seaweeds 
contain a high concentration of polysaccharides of varying structure and functionality which could 
potentially be exploited as prebiotics. 
3. Chemistry of Seaweed Polysaccharides 
The  chemical  structures  of  seaweed  polysaccharides  have  been  described  extensively  [31–35]. 
Contained  primarily  in  the  cell  walls,  key  functions  of  these  relatively  high  molecular  weight 
polysaccharides include, acting as a food reserve, provision of strength and flexibility to withstand 
wave action, maintenance of ionic equilibrium in the cell and prevention of cell desiccation. The 
composition varies according to season, age, species, and geographic location [36]. They are found 
with a wide variety of chemical structures, but some general characteristics have been identified [34]. 
They are rich in hydroxyl (-OH) groups, making them hydrophilic and often water soluble, and are 
known  to  establish  intra-chain  H-bond  networks,  making  them  stiff  and  rigid  and  suitable  as 
thickeners.  The  regularity  of  their  structures  also  promotes  interaction  with  external  ions  and  
inter-chain  H-bonding  (e.g.,  gelation).  Key  polysaccharides  found  in  chlorophyta,  phaeophyta  and 
rhodophyta are described in the following sections. 
3.1. Polysaccharides from chlorophyta 
Complex sulfated hetero-polysaccharides 
The cell wall matrix of chlorophyta contains highly complex sulfated hetero-polysaccharides [37]. 
The extracted polysaccharides from Ulva spp. (12% of the algal dry weight) have been reported to 
contain 16% sulfate and 15–19% uronic acids [38,39]. Each molecule of these heteropolysaccharides 
is  made  up  of  several  different  residues,  with  the  major  sugars  being  glucuronic  acid,  rhamnose, 
arabinose and galactose, in a variety of combinations [31]. Figure 3 shows the structures of rhamnose 
and glucuronic acid, two of the constituent sugars of green seaweed polysaccharides. 
The  polysaccharide  ulvan  is  easily  extracted  from  Ulva  rigida  [40,41].  It  is  composed  of  
β-(1,4)-xyloglucan,  glucuronan  and  cellulose  in  a  linear  arrangement  [31,41].  It  corresponds  to  a 
water-soluble dietary fiber and is resistant to both human digestive tract enzymes and degradation by 
colonic  bacteria.  This  polysaccharide  cannot  therefore  be  considered  prebiotic;  however,  it  could 
potentially be hydrolysed to bioactive oligosaccharides [42].  Mar. Drugs 2010, 8  
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Figure 3. Green seaweed constituents: (a) -L-rhamnose and (b) glucuronic acid [31]. 
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3.2. Polysaccharides from phaeophyta 
3.2.1. Alginates (also called alginic acid or algin) 
Alginic acid is an anionic polysaccharide that occurs in all brown algae. It is the most abundant cell 
wall polysaccharide in brown algae [43]. For example, the alginate content of a number of seaweeds, 
based  on  dry  weight,  is  as  follows:  Ascophylum  nodosum,  22–30%;  Laminaria  digitata  fronds,  
25–44%; L. digitata stipes, 35–47%; L. hyperborea fronds, 17–33%; L. hyperborea stipes, 25–38% 
[34]. Alginate contents of between 17 and 45% have been reported in Sargassum spp. [44,45]. The 
industrial process for the extraction of alginates from brown seaweeds is as follows [35]: 
  The seaweed is washed, macerated, extracted with sodium carbonate and filtered 
  Sodium/calcium chloride is added to the filtrate and a fibrous precipitate of sodium/calcium 
alginate is formed 
  The alginate salt is transformed to alginic acid by treatment with hydrochloric acid 
  The alginate is purified, dried and powdered 
Alginic  acid  is  a  linear  polysaccharide  containing  1,4-linked  β-D-mannuronic  acid  (M)  and  
α-L-guluronic acid (G) residues, arranged in a non-regular block-wise order along the chain [46]. The 
residues typically occur as (-M-)n, (-G-)n and (-MG-)n sequences or blocks [43]. The carboxylic acid 
dissociation constants have been determined as pKa = 3.38 and pKa = 3.65 for M and G, respectively, 
with similar values obtained for the polymers [47]. Figure 4 illustrates the structure of β-D-mannuronic 
acid and α-L-guluronic acid. 
Figure 4. Constituent acids of alginic acid, where (a) is -D-mannuronic acid and (b) is  
-L-guluronic acid [43]. 
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Mannuronic  and  guluronic  acids  are  classed  as  uronic  acids.  The  uronic  acids  are  simple 
monosaccharides in which the primary hydroxyl group at C6 has been oxidized to the corresponding 
carboxylic acid.  Their names  retain  the  root of  the  monosaccharides,  but  the  -ose  sugar  suffix  is Mar. Drugs 2010, 8  
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changed to -uronic acid. For example, galacturonic acid has the same configuration as galactose, and 
the structure of glucuronic acid corresponds to that of glucose. Uronic acids are present in all three 
algal divisions [31]. 
3.2.2. Fucans/Fucoidans 
Fucoidans are a complex series of sulfated polysaccharides found both intercellularly and in the cell 
wall of brown algae, with molecular weights typically of the magnitude 1,000,000. They play a role in 
cell organization and may be involved in the cross-linkage of alginate and cellulose [34]. Fucoidan is a 
water-soluble branched matrix polysaccharide sulfate ester, with L-fucose building blocks as the major 
component  with  predominantly  -(1,2)  linkages  [48].  Brown  algae  contain  5–20%  fucoidan  [44], 
about 40% of which is sulfate esters. The basic structure of fucoidan is shown in Figure 5. 
Fucoidans are reported to display physiological and biological activities, including anticoagulant, 
antithrombotic, antiviral, antitumor, immunomodulatory, antioxidant, and anti-inflammatory [49], with 
therapeutic potential increasing with the degree of  sulfation [34]. In  addition, they  protect gastric 
mucosa against the proteolytic activity of gastric juice. Furthermore, studies have demonstrated that 
fucoidan  may  prevent  Helicobacter  pylori  infection  in  the  stomach,  thereby  reducing  the  risk  of 
associated gastric cancers [50]. 
Figure 5. Fucoidan: Branched polysaccharide sulfate ester with L-fucose building blocks 
as the major component with predominantly -(1,2) linkages [43]. 
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3.2.3. Laminarin 
Laminarin is a relatively low molecular weight storage polysaccharide found commonly in brown 
algae.  It  may  constitute  up  to  35%  of  the  dried  weight  of  the  seaweed  [34].  A  member  of  the  
1-3-β-D-glucan family, laminarin, consists of a linear structure with a small degree of side branching 
[51]. It is composed of (1,3)-β-D-glucopyranose residues, in which some 6-O-branching in the main 
chain and some β-(1,6) intrachain links are present (Figure 6 and Table 1) [52]. Laminarins from 
different algal species may vary in structural features; for example the degree of branching, the degree 
of polymerization (up to 50 carbohydrate residues, commonly about 25), and the ratio of (1,3)- and 
(1,6)-glycosidic bonds [52]. Most laminarins form complex structures that are stabilized by inter-chain Mar. Drugs 2010, 8  
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hydrogen bonds and are therefore resistant to hydrolysis in the upper GIT and are considered as dietary 
fibers [53]. 
Laminarin has been identified as a modulator of intestinal metabolism through its effects on mucus 
composition, intestinal pH and short chain fatty acid (SCFA) production, especially butyrate [54,55] 
(see Section 4.3). 
Figure 6. Basic chemical units of laminarin, made up of β-(1,3) and β-(1,6) linked glucose. 
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Table 1. Chemical structure of laminarins from various seaweeds [34]. 
Seaweed  Structure of Laminarin 
Several species of Laminaria  Linear β-(1,3) linked D-glucose 
Laminaria digitata  Linear backbone of β-(1,3) linked D-glucose, with β-(1,6) linked side chains 
Eisenia bicyclis  Linear chain of (1–3) and (1–6) links, in the ratio of 2:1 
3.3. Polysaccharides from rhodophyta 
Most  red  algal  polysaccharides  are  galactans  in  which  α-(1,3)  and  β-(1,4)  links  alternate  [31]. 
Variety  in  the  polysaccharides  comes  from  sulfation,  pyruvation  and  methylation  of  some  of  the 
hydroxyl groups and from the formation of an anhydride bridge between C3 and C6.  
3.3.1. Agar 
Agars,  the  gel-forming  polysaccharides  extracted  from  certain  families  of  rhodophyta,  mainly 
Gracilariaceae and Gelidiaceae [56], are linear polymers with a sugar skeleton consisting of alternating 
3-linked  β-D-galactopyranosl  and  4-linked  3,6-anhydro-α-L-galactopyranosyl  units  [57].  The  basic 
structure of the constituent galactose residues is shown in Figure 7. Agar may be fractionated into two 
components [58]: 
  Agarose (the gelling fraction)—A neutral linear molecule, free of sulfates 
  Agaropectin  (the  non-gelling  fraction)—Contains  all  the  charged  polysaccharide  
components,  with  some  galactose  residues  substituted  with  pyruvic  acid  ketal,  
4,6-O-(1-carboxyethylidene)D-galactopyranose,  or  methylated  or  sulfated  sugar  units  [58]. 
Agaropectin is a slightly branched heterogeneous mixture of smaller molecules. 
The ratio of the two fractions varies according to seaweed species and environmental conditions, 
and  will affect  the  physiochemical,  mechanical  and  rheological  properties  of  agar.  The  molecular 
weight of agarose is about 120,000. Due to the substitutions in agaropectin, the molecular weight of 
agar is typically higher (up to 250,000), with a wide distribution [58]. 
Agarose  is  widely  used  as  a  gelling  agent  in  microbiological  media  and  for  biotechnological 
applications [34]. Hu et al. [59] found that neoagaro-oligosaccharides (NAOS), obtained from the Mar. Drugs 2010, 8  
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enzymatic hydrolysis of agarose, demonstrated prebiotic activity which was dependant on the degree 
of polymerization (see Section 4.2). 
Figure 7. Agar constituents [31] (R=H or CH3). 
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3.3.2. Carrageenans (sulfated polysaccharides) 
In carrageenans, β-D-galactose alternates with α-D-galactose, not α-L-galactose as in agars. The 
degree of sulfation in carrageenans is generally much greater than that in agars. Based on physical 
properties, carrageenans are commonly classified into three types; kappa (strong rigid gels), iota (soft 
elastic gels) and lambda (thickening polymer) [34]. The basic structures of the three classes are shown 
in Figure 8. 
Carrageenans are used in a wide variety of applications; for example, as thickening, stabilizing and 
encapsulation agents. It has been reported that degraded carrageenans may cause ulcerations in the 
GIT and gastrointestinal cancer [34]. 
Figure 8. Basic structure of kappa-, iota-, and lambda-carrageenan [60]. 
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3.3.3. Other polysaccharides and polysaccharide derivatives 
The presence of uronic acids in red seaweed polysaccharides has been reported. For example, a 
neutral xylan and a xylogalactan, with 4.8% uronic acids, were obtained from Palmaria decipiens [32]. 
Errea et al. [61] reported unusual structures in polysaccharides from the red seaweed Pterocladiella Mar. Drugs 2010, 8  
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capillacea.  Structural  analysis  indicated  the  presence  of  xylogalactans,  with  a  low  content  of  
3,6-anhydrogalactose  and  low  molecular  weight.  The  polysaccharides  varied  in  the  degree  of 
xylopranosyl  and  sulfate  substitution.  The  presence  of  3-substituted,  4-linked  D-galactopyranosyl 
residues was also reported.  
A number of potentially useful sulfated polysaccharides from lesser-known red seaweed species 
have been reported [34]: 
  Hypneans are extracted from the Hypnea spp. Structurally, hypneans are similar to agar and 
carrageenan, but with a higher percentage of 3,6-anhydrogalactose. They are primarily used as 
gelling agents in food applications and as fertilizers in dry arid soils. 
  Porphyran is a highly substituted polysaccharide extracted from the Porphyra genus. It is used as 
a gelling agent, a nutritional supplement (e.g., to help cope with stress) and an antioxidant. 
  Funorans,  extracted  from  species  such  as  Gloiopeltis  complanata,  are  composed  of  a 
heterogeneous  series  of  polysaccharides  and  sulfated  galactans.  Funoran  has  been  shown  to 
inhibit the adherence and colonization of oral bacteria, reducing dental caries in rat studies [62]. 
It is also reported to reduce blood pressure, lower cholesterol and exhibit anti-tumor properties. 
Oligosaccharides  are  commonly  defined  as  carbohydrate  molecules  with  a  low  degree  of 
polymerization (between 2 and 25) [19]. These molecules may be found naturally or derived from 
larger polysaccharides. Examples of depolymerization methods for algal polysaccharides include; free 
radical depolymerization for fucoidan, thermal degradation and enzymatic hydrolysis for alginate and 
chemical  degradation  for  ulvan.  While  numerous  studies  have  reported  prebiotic  activity  for  
plant-derived oligosaccharides [19], few studies have specifically examined the effects of algal-derived 
oligosaccharides (see Section 5.1). 
4.  In  Vitro  Studies  Examining  the  Prebiotic  Potential  of  Seaweed  Polysaccharides  and 
Oligosaccharide Derivatives 
While  prebiotic  activity  must  ultimately  be  determined  in  vivo,  in  vitro  studies  are  useful  for 
preliminary  screening  of  candidate  compounds  and  can  generate  information  on  functional 
mechanisms. The three main criteria that are tested in vitro are; non-digestibility, fermentability and 
selectivity [20]. Studies that have evaluated seaweeds and/or seaweed polysaccharides in vitro will be 
reviewed here.  
4.1. Resistance to digestive enzymes 
As discussed in Section 2, a prebiotic compound must be resistant to digestion in the upper GIT so 
that it can reach the lower intestine intact [18]. This can be investigated in vitro by testing resistance to 
acidic and enzymatic hydrolysis. Hu et al. [59] showed that agarose-derived NAOS were resistant to 
amylolytic enzymes by demonstrating via electrophoretic analysis that the compounds remained intact 
after 24 h incubation with an enzyme mixture. Similarly, glycerol galactoside, determined to be the 
fermentable component of the red alga  Porphyra yezoensis, was not digested by salivary, gastric, 
pancreatic or intestinal enzymes [63]. Neither was it absorbed across excised segments of rat small 
intestine. A study by Deville et al. [55] showed that laminarin remained intact following incubation 
in vitro with HCl, human saliva and human gastric, pancreatic, small intestinal and colonic homogenates. Mar. Drugs 2010, 8  
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4.2. Selective fermentation by pure cultures 
One  of  the  criteria  that  a  compound  must  meet  in  order  to  be  classified  as  a  prebiotic  is 
―fermentation  by  intestinal  microbiota‖  [18].  Compounds  should  be  selectively  fermented,  i.e., 
fermentable by beneficial species but not pathogens (Figure 1). This can be determined in vitro by 
incubating  pure  cultures  of  representative  beneficial  bacteria  (usually  Lactobacillus  and 
Bifidobacterium spp.) as well as potentially pathogenic species (e.g., E. coli, Enterococcus) with the 
compound and investigating bacterial growth [18]. The usual procedure is to inoculate a range of 
bacterial strains into a microbiological medium in which the carbon source has been replaced by the 
test compound and measure growth in comparison to a glucose control. While many studies have 
evaluated  potential  prebiotics  in  this  way  [16],  few  have  evaluated  seaweed-derived  compounds. 
However, studies conducted more than three decades ago showed that laminarin and alginate could be 
degraded by human colonic bacteria [64,65]. Hu et al. [59] showed that NAOS obtained from agarose 
were  fermented  by  Lactobacillus  and  Bifidobacterium  but  not  E.  coli  or  Enterococcus.  Increased 
growth  rates,  as  determined  by  plate  counts  and  pH  decrease,  were  observed  in  comparison  to  
fructo-oligosaccharides (FOS) but glucose was not included as a control. Nori, a dried form of the red 
seaweed Porphyra yezoensis, was fermented by all but one of five intestinal Bifidobacterium strains, 
but only when it had a high protein content [63]. In a subsequent experiment with 17 bacterial strains, 
glycerol galactoside, which was determined to be the fermentable component, was comparable with 
glucose as a substrate for Bifidobacterium. It was also fermented by Bacteroides, Clostridium and 
E. coli, albeit not as well as glucose but failed to stimulate the growth of Enterococcus, Eubacterium 
or Lactobacillus spp. 
These results, while useful, should be interpreted with caution, as the test strains and conditions 
used may not be representative of those found within the intestinal tract. Therefore, these types of 
assays are recommended only as a screening tool in preliminary investigations [18]. 
4.3. Fermenter studies to determine effects on intestinal microbiota 
A  more  meaningful  way  to  assay  potential  prebiotic  compounds  is  to  test  them  in  anaerobic 
fermenter systems inoculated with fecal/intestinal material [66]. This not only tests the ability of the 
intestinal  microflora  to  ferment  the  compound  but  also  evaluates  stimulatory  effects  on  microbial 
growth and/or activity. Effects on microbial growth can be monitored by culturing fermenter samples 
on selective media; however, culture-independent approaches employing molecular methods such as 
fluorescece in situ hybridization (FISH), polymerase chain reaction (PCR), denaturing gradient gel 
electrophoresis (DGGE) and 16S rRNA gene sequencing provide a more complete representation of 
microbial diversity [18]. Microbial activity is usually evaluated by measuring metabolic end products, 
such as SCFA and gases. 
Total algal fibers extracted from whole Himanthalia elongata, L. digitata and Undaria pinnatifida 
were fermented by human fecal microflora after 24 h in a batch system, as determined by substrate 
disappearance, but were not completely metabolized to SCFA compared with sugarbeet fiber [67]. In a 
subsequent experiment, purified laminarins were highly fermented after an initial lag period (explained 
by the time required for induction of bacterial enzymes), alginates were fermented but not completely Mar. Drugs 2010, 8  
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degraded to SCFA and fucans were not fermented at all. However, effects on microbial counts were 
not evaluated, so no conclusions on prebiotic activity can be made. 
Deville et al. [54] showed that laminarin (either extracted from L. saccharina or L. digitata) was 
almost completely fermented in a human fecal batch fermenter system after an initial lag period, as 
measured by its disappearance over 48 h. Turbidity increases and pH decreases (both indicative of 
bacterial growth) were comparable in vessels containing laminarin, FOS or glucose after 24–48 h. 
Total SCFA concentrations were higher for L. digitata laminarin in comparison to glucose with higher 
amounts  of  propionate  and  butyrate  observed.  SCFA  were,  however,  not  measured  for  the 
L. saccharina-derived  laminarin  or  FOS  treatments.  Furthermore,  while  FOS  increased  culturable 
Lactobacillus and decreased Bacteroides, laminarin had no effects on bacterial counts. Although PCR 
was  used  to  confirm  counts,  no  culture-independent  analyses  were  performed.  Similarly,  SCFA 
concentrations increased in a human fecal batch culture on addition of laminarin or alginate compared 
to a control [68]. Reduced concentrations of potentially harmful microbial end products (ammonia, 
indole compounds, phenol compounds) were also observed. Taken together, this data was interpreted 
as an indication of fermentation of the seaweed polysaccharides by intestinal bacteria but, as is the 
case  in  many  studies,  no  microbiological  analyses  were  performed.  However,  Dierick  et  al.  [69] 
demonstrated  that  dried  whole  Ascophyllum  nodosum  decreased  potential  pathogens  (E.  coli, 
streptococci) and total anaerobes in batch systems inoculated with either porcine small intestinal or 
cecal suspensions. This inhibitory activity may have been due to the reduction in pH, as the pH was 
not controlled during fermentation. However, a decrease in beneficial bacteria (i.e., Lactobacillus) was 
also observed. The authors concluded that this intact brown seaweed is not a suitable fermentation 
substrate,  however,  further  experiments  were  not  conducted  to  evaluate  this  and  only  culturable 
microflora was investigated. Furthermore, the control vessel contained a synthetic diet which would 
have  supplied  all  of  the  nutrients  necessary  for  microbial  growth,  while  the  experimental  vessels 
contained  seaweed  only.  In  practice,  diets  would  be  supplemented  with  A.  nodosum,  rather  than 
consisting entirely of seaweed. 
Michel et al. [70] evaluated alginate- and laminarin-derived oligosaccharides in continuous as well 
as batch human fecal fermentations compared with FOS. While total concentrations of SFCA did not 
differ between treatments, propionate production was increased by all of the test compounds relative to 
FOS. These and additional data reported in the study indicated that the oligosaccharides tested were 
fermented by the fecal microflora [70]. However, oligosaccharides from either source did not alter 
counts of Bacteroides, Lactobacillus, total anaerobes or aerobes and, in fact, Bifidobacterium counts 
were reduced ~1000-fold. The latter is in keeping with the reductions in Lactobacillus observed by 
Dierick et al. [69]. 
The most promising evidence of prebiotic activity of algal polysaccharides comes from a recent 
study that evaluated the effects of a dietary supplement containing a mixture of plant polysaccharides 
including Undaria pinnatifida fucoidans on human fecal microflora in a three-vessel colon model [71]. 
No control vessels were used; instead there was a control period before supplement addition and a 
washout  period  after.  The  product tested  was predominantly  fermented  in  the  distal colon  vessel. 
Although no effects on total SCFA were observed before, during or after supplement addition, lactate 
and butyrate were decreased in the ascending and descending colon vessels, respectively during the 
treatment period. Although some increases in individual SCFA were observed during the washout Mar. Drugs 2010, 8  
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period (most notably butyrate in the distal colon), a concomitant increase in ammonium, a potentially 
toxic metabolite, was observed in the descending colon during treatment. It is encouraging to note that 
increases  in  Bifidobacterium  were  seen,  both  via  plate  counts  and  quantitative  PCR  (qPCR). 
Furthermore, DGGE revealed compositional changes within bifidobacterial populations. Cultivable 
Lactobacillus were increased but qPCR failed to show such an effect, although it did reveal increases 
in the Bacteroides-Prevotella group. Taken together, these data demonstrate that the product tested 
appears promising as a prebiotic; however, as it was a mixture of plant-derived polysaccharides, no 
conclusions can be made regarding prebiotic activity of the seaweed fucoidan component.  
Overall, a number of studies mainly conducted in batch fermentation systems have demonstrated 
that seaweed polysaccharides are fermented by the intestinal microflora but few demonstrate selective 
stimulation  of  beneficial  intestinal  microbial  populations.  Additional  studies  in  multi-chamber 
continuous  culture  systems  are  needed,  as  these  replicate  different  gastrointestinal  regions  more 
closely. Even these systems suffer limitations, as an increase in a limited number of bacterial genera 
within a complex mixture is not definitive proof of a prebiotic effect. Further studies utilizing detailed 
molecular methods, such as metagenomics, are required in order to fully elucidate the impact of algal 
polysaccharides on the entire intestinal microbiome.  
5.  In  Vivo  Studies  Examining  the  Prebiotic  Potential  of  Macroalgal  Polysaccharides  and 
Oligosaccharide Derivatives 
In vitro studies give an indication of the prebiotic potential of algal polysaccharides. However, 
in vivo studies are necessary to demonstrate prebiotic activity before worthwhile conclusions may be 
drawn. While there is substantial evidence in the literature to suggest that certain polysaccharides such 
as inulin and FOS have modulatory effects on the gut microflora in humans, to date no human trials 
have been conducted on polysaccharides from seaweeds. Studies have, however, been conducted in 
laboratory  animals  to  determine  prebiotic  properties  of  seaweed  polysaccharides  with  a  view  to 
establishing suitability for applications in other animals and humans. Feeding trials have also been 
performed in farm animals to investigate effects on animal health and growth performance. 
5.1. Studies in laboratory animals 
Wang  et  al.  [72]  demonstrated  that  rats  fed  test  diets  supplemented  with  2.5%  alginate 
oligosaccharides displayed a selective increase in the numbers of Bifidobacterium and Lactobacillus in 
both the cecum and feces. The prebiotic effect was greater than that observed in the control group 
which was fed a diet containing FOS, a well-established prebiotic. A study conducted by Hu et al. [59] 
demonstrated similar increases in fecal Lactobacillus and Bifidobacterium populations after feeding 
mice diets supplemented with either 2.5% or 5% agarose hydrolysate (NAOS) compared with a control 
diet or a diet containing FOS. The authors also demonstrated that the NAOS-fed group had increased 
Lactobacillus  counts in the  cecum seven days post-administration compared  to  the  control group; 
however, cecal Lactobacillus counts in the test group were similar to those in the group fed FOS. In 
addition, the NAOS-fed group had lower numbers of  Bacteroides compared to the control group. 
Overall, the NAOS-fed groups demonstrated large increases in populations of beneficial bacteria, with 
no  adverse  effects  on  animal  health,  suggesting  that  NAOS  could  be  a  potential  algal  prebiotic. Mar. Drugs 2010, 8  
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Kuda et al. [68] reported that dietary supplementation with 1% laminarin resulted in an increase in 
Bifidobacterium counts in the cecum of rats compared to a control diet, but there was no significant 
difference in Lactobacillus counts. In the same study, laminarin was shown to suppress indole, cresol 
and  sulfide,  which  are  putrefactive  compounds  considered  risk  markers  for  colon  cancer.  Further 
evidence that laminarin is fermented by the intestinal microbiota was found in a study which showed 
that laminarin was not detected in the feces of rats fed laminarin [55]. A study by Gudiel-Urbano and 
Goni [73] demonstrated that rats fed Undaria pinnatifida and Porphyra ternera extracts had lower 
bacterial enzyme activity in the cecum. This provides additional indirect evidence of the effects of 
seaweed extracts on the intestinal microflora. Furthermore, the enzymatic activities that were reduced 
are implicated in the conversion of procarcinogens to carcinogens, suggesting a possible link between 
seaweed  extract  intake  and  reduced  risk  of  colon  cancer  (also  implied  from  data  generated  by 
Kuda et al. [68], as outlined above). Neyrinck et al. [53] demonstrated that dietary supplementation 
with  laminarin  also  has  systemic  effects,  as  it  protected  against  lipopolysaccharide-induced  liver 
toxicity  in  a  rodent  model  of  systemic  inflammation.  Dietary  laminarin  had  immunomodulatory 
effects, which the authors suggest are due either to a direct effect of laminarin on immune cells or to an 
indirect effect via modulation of the intestinal microbiota. However, intestinal microbial populations 
were not measured so no conclusions can be made regarding the latter. Overall, from the studies 
conducted  to  date,  it  is  evident  that  seaweed  polysaccharides  and  oligosaccharide  derivatives 
demonstrate prebiotic effects in rodents. 
5.2. Studies in farm animals  
Prebiotics  have  a  role  to  play  in  animal  health;  they  are  assumed  to  stimulate  the  growth  of 
beneficial bacteria, thereby improving intestinal health and stimulating growth performance, particularly 
following weaning. The post-weaning period in pigs is stressful due to factors such as separation from 
the sow and littermates, digestive disruption as a result of the sudden shift from milk to a cereal-based 
diet and exposure to a new environment [74]. These stressors can cause a microbial imbalance in the 
gut, leading to undesirable effects such as reduced feed intake, a consequential reduction in growth 
rate and increased susceptibility to post-weaning diarrhea and pathogenic infections [75]. Modulation 
of the gut microbiota by prebiotics may prove to be a useful strategy in promoting growth and may 
alleviate some of the undesirable effects observed in weanling pigs. Many studies have evaluated the 
effects of seaweed extracts and seaweed polysaccharides, such as laminarin in feeding experiments, 
mainly in pigs but also in lambs and cattle. Such experiments have been conducted as seaweed extracts 
and  seaweed  polysaccharides  are  considered  good  prebiotic  candidates  as  they  are  resistant  to 
digestion in the small intestine and are fermented by colonic microbiota, as outlined in section 4 
[54,55]. However, the differences in digestive physiology and anatomy must be borne in mind when 
attempting  to  extrapolate  data  from  ruminants  (cattle  and  sheep)  to  pigs,  which  are  monogastric. 
Effects  on  parameters,  such  as  growth  performance,  nutrient  digestibility,  volatile  fatty  acids  and 
intestinal microbiota have been studied in detail, particularly in relation to swine health and nutrition 
and will be reviewed below. Only statistically significant results (cut-off of P < 0.05) are discussed. Mar. Drugs 2010, 8  
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5.2.1. Effects of marine polysaccharides on growth performance 
Reilly et al. [76] found that dietary inclusion of seaweed extracts containing both laminarin and 
fucoidan had no effect on feed intake, weight gain, feed conversion ratio or nutrient digestibility in 
weanling pigs (Table 2). A lack of improvement in weight gain, feed intake and feed efficiency has 
also  been  reported  in  finishing  lambs  fed  diets  supplemented  with  Tasco  14™  (sun-dried  whole 
A. nodosum) [77]. Furthermore, Gardiner et al. [78] found no effects on feed intake or feed conversion 
ratio but reported a decrease in weight gain when an A. nodosum extract was fed to grower-finisher 
pigs (Table 2). The authors suggested that the presence of anti-nutritional phyto-chemicals and a high 
level of chelated metals in the crude seaweed extract may have been responsible for the decreased 
growth performance. As a consequence, Gahan et al. [79] supplemented diets with a more refined 
seaweed extract containing only laminarin and fucoidan with a view to replacing lactose in the diet of 
weaned pigs. The authors extract increased feed intake and weight gain and improved feed conversion 
ratio in a manner similar to lactose (Table 2).  
High health status of animals is often cited as a reason for lack of effects on growth performance. 
For this reason, McDonnell et al. [80] fed pigs a nutritionally challenged diet supplemented with 
laminarin and found increased weight gain and increased gain to feed ratio (equivalent to reduced feed 
conversion ratio). However, fucoidan had no effect on pig growth or daily feed intake. A more recent 
study conducted by O’Doherty et al. [81] reported that dietary inclusion of a laminarin-fucoidan extract 
increased average daily weight and gain to feed ratio in pigs fed diets formulated to create a nutritional 
challenge,  similar  to  those  fed  by  McDonnell  et  al.  [80]  (Table  2).  Similarly,  Turner  et  al.  [82] 
observed  a  positive  linear  effect  on  feed  intake  and  a  quadratic  effect  on  weight  in  young  pigs 
challenged with Salmonella and fed an A. nodosum extract. 
Overall, the evidence examining the effect of seaweed extracts on growth performance in farm 
animals is equivocal, a trend which is also observed in studies examining the effects of established 
prebiotics in animals [30]. Reasons for the differences in responses observed between studies may be 
due to factors such as, differences in dietary inclusion levels, variations in the types and purity of 
seaweed  extracts  evaluated  and  differences  in  the  species,  age  and  health  status  of  animals  used 
(Table 2). Additional studies examining the effects of purified polysaccharides from seaweeds are needed. 
5.2.2. Effects on intestinal microflora 
In addition to the studies conducted in rodents (see Section 5.1), a number of research groups have 
examined  the  effect  of  feeding  seaweed  extracts  on  the  gut  microflora  of  farm  animals. 
Dierick et al. [69] reported that inclusion of A. nodosum meal in the diets of weanling pigs resulted in 
lower  numbers  of  E.  coli  in  the  small  intestine.  Furthermore,  the  authors  reported  that  the  small 
intestinal Lactobacillus/E. coli ratio was increased in the test group indicating a potentially beneficial 
shift in the microbial ecosystem. However, Gardiner et al. [78] reported that dietary supplementation 
with a crude A. nodosum extract in finisher pigs resulted in reduced ileal coliform counts but also 
reduced cecal bifidobacteria, which are considered beneficial (Table 2). Similarly Reilly et al. [76] 
reported reductions in enterobacteria but also bifidobacteria and lactobacilli in the cecum and/or colon 
of weaned pigs fed L. digitata containing laminarin and fucoidan. Similar effects were seen in a group Mar. Drugs 2010, 8  
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fed  L.  hyperborea  (also  containing  laminarin  and  fucoidan),  but  there  were  no  reductions  in 
enterobacteria. However, a combination of both extracts resulted in a reduction of enterobacteria and 
lactobacilli  in  the  cecum  and  colon  but  no  effects  on  bifidobacteria  were  observed  (Table  2). 
Lynch et al. [83] found that finisher pigs offered diets supplemented with increasing amounts of an 
intact L. hyperborea extract had reduced cecal Bifidobacterium and colonic Lactobacillus counts [76]. 
In a subsequent experiment also in finisher pigs, dietary supplementation with a purer fucoidan extract 
increased  Lactobacillus  counts  in  the  proximal  and  distal  colon  (Table  2).  On  the  other  hand, 
McDonnell et al. [70]  demonstrated  that  weanling  pigs  offered  diets  supplemented  with  laminarin 
alone or laminarin in combination with fucoidan had reduced fecal E. coli counts compared to pigs fed 
diets without laminarin. However, laminarin alone or in combination with fucoidan did not affect fecal 
lactobacilli  but  fucoidan  alone  resulted  in  higher  counts  of  fecal  lactobacilli  compared  to  control 
animals (Table 2). The authors suggest that fucoidan has antimicrobial activity, while laminarin exerts 
prebiotic  activity.  In  another  study,  O’Doherty  et  al.  [81]  hypothesized  that  a  laminarin-fucoidan 
seaweed  extract  might  prevent  any  negative  effects  of  lactose  removal  from  weanling  pig  diets. 
Inclusion of seaweed extract in either high or low lactose diets resulted in decreased fecal E. coli 
counts compared to non-seaweed diets. Decreases were similar to those observed in pigs fed high 
lactose diets alone. Increased lactobacilli numbers were also observed in pigs fed diets supplemented 
with seaweed extract but only in combination with high lactose levels. Janczyk et al. [84] reported that 
dietary supplementation with alginate resulted in higher enterococci counts in the distal small intestine, 
cecum and proximal colon of weanling pigs after an 11-day administration period compared with 
inulin  or  a  control  diet.  However,  reductions  in  lactobacilli  were  also  observed  in  all  intestinal 
segments but only after 6 days of alginate supplementation, and not prior to or after this timepoint. 
Molecular analysis of the intestinal microbiota by DGGE also demonstrated higher microbial diversity 
in the distal small intestine of alginate-supplemented pigs compared to animals fed a control diet. To 
our knowledge this is the only study to date that has examined effects of a seaweed polysaccharide on 
the intestinal microflora at a molecular level. Dietary supplementation with prebiotic compounds is 
also promising as a means of reducing pathogen shedding in farm animals as a strategy to improve 
food  safety.  Braden  et  al.  [85]  examined  the  effects  of  dietary  supplementation  with  2%  dried 
A. nodosum (Tasco 14
TM), on fecal enterohemorrhagic E. coli O157:H7 populations on cattle hides and 
in feces. The authors reported reductions in the prevalence of fecal E. coli O157 and O157:H7 in hide 
swabs and fecal samples of A. nodosum-supplemented animals compared to animals offered a control 
diet. Bach et al. [77] also examined the effect of feeding Tasco 14
TM on E. coli O157:H7 shedding but 
in cattle deliberately challenged with the pathogen. E. coli O157:H7 detection was less frequent in 
fecal samples of animals fed diets supplemented with either 10 g/kg of Tasco 14
TM for 14 days or 
20 g/kg for seven days compared to animals fed the control diets or diets supplemented with 20 g/kg 
for 14 days. The exact mode of action of the seaweed extract was not identified in either study but 
inhibitory effects against E. coli were attributed to direct antimicrobial activity rather than a prebiotic 
effect. This was concluded due to a lack of effects on microbial metabolites in the feces, indicating that 
the seaweed extract did not alter intestinal microbial populations and was therefore not fermented; 
however, only fecal metabolites were measured and further studies are warranted to explore effects on 
colonic microflora. Mar. Drugs 2010, 8  
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Overall, while increases in beneficial intestinal microbial populations are seen in some experiments 
where  animals  were  fed  seaweed-extracts,  there  is  evidence  to  show  that  feeding  purer  extracts 
containing known amounts of characterized polysaccharides may be more effective in achieving a 
prebiotic  effect.  On  the  other  hand,  some  extracts  result  in  decreases  in  Gram  negative intestinal 
populations but are not selective, as concomitant decreases in populations considered beneficial are 
sometimes also observed. This is most likely due to a direct antimicrobial effect rather than prebiotic 
activity. It has been suggested that certain seaweed polysaccharides may exert inhibitory effects while 
others might stimulate microbial populations and for this reason polysaccharides should perhaps be fed 
in combination. 
In addition to examining the effects of potential prebiotic compounds on gut microbial ecology, 
microbial activity  can be  elucidated by examination of fermentation  end  products such  as  SCFA. 
These are predominantly produced in the hindgut which is where they exert the majority of their 
effects.  For  example,  within  the  colon,  SCFA  are  a  source  of  energy  for  the  host  but  also  have 
important effects  on host epithelial physiology [86].  SCFA also  stimulate gut  integrity  and lower 
intestinal pH, which is associated with a reduction in pathogen growth [87]. Lynch et al. [83] observed 
that a crude L. hyperborea extract resulted in changes in the concentration of total fatty acids and 
molar proportions of individual fatty acids in the cecum but not the proximal colon of finisher pigs. 
However, Reilly et al. [76] demonstrated that supplementation with a crude L. hyperborea extract 
increased the concentration of colonic volatile fatty acids, whilst an extract derived from L. digitata 
increased  volatile  fatty  acids  in  the  cecum  of  weanling  pigs.  Therefore,  extracts  from  different 
seaweeds, although similar in laminarin and fucoidan content, are fermented in different areas of the 
GIT and this may be due to differences in the purity of these extracts. It is also apparent that results 
can  also  vary  between  studies  even  when  the  same  seaweed  is  fed;  this  was  perhaps  due  to  the 
differing age of the animals used. In a subsequent experiment, Lynch et al. [83] examined the effects 
of purified laminarin, fucoidan and a combination of both on the concentration of fatty acids in the 
proximal and distal colon (but not the cecum) of finishing pigs. Interestingly, the fucoidan-supplemented 
diet increased total fatty acid concentrations in the proximal and distal colon; there were however, no 
changes in fatty acid concentrations in the proximal colon of pigs fed the crude seaweed extract, as 
outlined above. This indicates that the purified polysaccharides were broken down to a greater extent 
than the crude extract. McDonnell et al. [80] reported increases in fecal lactobacilli populations in 
weanling animals offered a laminarin-fucoidan extract, however, no changes in fecal fatty acids in this 
group  were  observed.  Similarly,  O’Doherty et al. [81]  reported  increases  in  Lactobacillus  spp.  in 
weanling pigs fed a laminarin-fucoidan extract in combination with a high lactose diet but reported no 
effects on total fecal volatile fatty acid concentrations or the fatty acid profile. However, measurement 
of fecal volatile fatty acids in pigs may not be indicative of the degree of fermentation in the large 
intestine, as the fatty acids produced in the cecum and colon will most likely have been absorbed there 
and hence will not be excreted in the feces.  
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Table 2. Effects of algal prebiotics on pig health. 
Algal supplement  Age and heath 
status of pigs 
Dose  Effect on gut microbiota  Effect on growth performance 
and health 
Ref 
A. nodosum extract (ANE)  Healthy 
grower-finisher 
pigs 
0, 3, 6 or 9 g/kg basal 
feed 
Animals supplemented with 6 or 9 g ANE/kg 
had lower (P < 0.05) ileal coliform counts 
than animals that received 3 g/kg 
Linear reduction (P < 0.05) in coliform counts 
in the ileal contents as ANE increased 
Reduction (P < 0.05) in cecal Bifidobacterium 
counts with increasing ANE supplementation 
Linear decrease (P < 0.05) in 
weight gain with increasing 
levels of extract 
[78] 
A. nodosum meal (ANM)  Healthy, 
weanling 
piglets 
10 or 20 g/kg basal feed  Reduced (P < 0.05) E. coli in the small 
intestine and increased (P< 0.05) 
Lactobacillus/E. coli ratio in animals fed 10 g/kg 
No effects on final weight 
No effects on intestinal histology 
or intestinal immune cells 
[69] 
Laminaria spp. extract 
containing a combination 
of laminarin & fucoidan 
(ranging from 0.112–0.446 
and 0.890–0.356 g/kg, 
respectively) 
Healthy, 
weanling 
piglets 
0, 1, 2, 4 g/kg basal 
feed containing 
increasing levels of 
lactose (60–250 g/kg) 
Effects on gut microbiota were not 
determined 
Weight gain and feed intake 
increased (P < 0.05) as the level 
of seaweed extract increased; 
however, this was only observed 
when fed in combination with 
low and medium levels of lactose 
[79] 
Laminaria spp. extract 
containing either laminarin 
or fucoidan or a 
combination of both (0.3 
and 0.24 g/kg, 
respectively) 
Healthy, 
weanling 
piglets fed a 
nutritionally-
challenged diet 
(high protein, 
low lactose) 
Basal feed + 0.3 g/kg 
laminarin; 
basal feed + 0.24 g/kg 
fucoidan; 
basal feed + 0.3 g/kg 
laminarin and 0.24 g/kg 
fucoidan 
Laminarin supplementation resulted in lower 
(P < 0.05) fecal E. coli populations compared 
to control group 
Interaction (P < 0.01) between laminarin and 
fucoidan with respect to fecal lactobacilli 
populations 
Laminarin supplementation 
resulted in increased (P < 0.01) 
daily weight gain 
Pigs offered combination of 
laminarin and fucoidan had 
reduced (P < 0.05) diarrhoea 
[80] Mar. Drugs 2010, 8  
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Table 2. Cont. 
Algal supplement  Age and heath 
status of pigs 
Dose  Effect on gut microbiota  Effect on growth 
performance and 
health 
Ref 
Alginate  Healthy, 
weanling 
piglets 
1 g/kg starter feed  Higher enterococci counts in distal small 
intestine, cecum and proximal colon (P < 0.001) 
compared with inulin or control group. 
Reduced (P < 0.05) lactobacilli in all intestinal 
segments but only after 6 days of alginate 
supplementation, and not before or thereafter 
Increased microbial diversity 
Animals were in good 
health throughout the 
study 
[84] 
Exp 1: 
L. hyperborea extract (112 g/kg 
laminarin & 89 g/kg fucoidan) 
Exp 2: 
Purified laminarin (0.30 g/kg), 
fucoidan (0.24 g/kg) and a 
combination of both laminarin 
and fucoidan (0.30 and 0.24 g/kg, 
respectively) 
Healthy 
finishing boars 
Exp 1:0.7, 1.4, 2.8, 
5.6 g/kg extract 
Exp 2: 
Basal diet + 0.30 g/kg 
laminarin; 
basal diet + 0.24 g/kg 
fucoidan; 
basal diet + 0.30 g/kg 
laminarin and  
0.24 g/kg fucoidan 
Exp 1: 
Quadratic response (P < 0.05) to seaweed extract 
on cecal (P < 0.05) Enterobacterium spp., colonic 
(P < 0.05) Enterobacterium spp. and (P < 0.001) 
Bifidobacterium spp. 
Linear decrease in cecal Bifidobacterium spp and 
colonic Lactobacillus spp. with increasing 
seaweed extract (P < 0.01, P < 0.05, respectively) 
Exp 2: 
Fucoidan diet resulted in increases in colonic 
Lactobacillus spp. (P < 0.001). 
Combination diet resulted in increase in 
Enterobacterium spp. (P < 0.05). 
Growth performance was 
not evaluated 
[83] Mar. Drugs 2010, 8  
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Table 2. Cont. 
Algal supplement  Age and heath 
status of pigs 
Dose  Effect on gut microbiota  Effect on growth 
performance and health 
Ref 
L. hyperborea extract 
(LHE), containing 
laminarin and fucoidan 
(0.17 and 0.13 g/kg, 
respectively) 
L. digitata extract 
(LDE), containing 
laminarin and fucoidan 
(0.17 and 0.14 g/kg, 
respectively) 
Combination of LHE 
and LDE containing 
laminarin and fucoidan 
(0.17 and 0.13 g/kg, 
respectively) 
Healthy, 
weanling 
piglets 
Basal feed + 1.5 g/kg LHE 
Basal feed + 1.5 g/kg LDE 
Basal feed + 1.5 g/kg LHE & 
LDE 
Animals offered LHE diet had lower  
(P < 0.05) numbers of colonic Bifidobacterium 
and lower populations of cecal and colonic  
(P < 0.05, P < 0.001, respectively) lactobacilli 
compared to control diet 
Supplementation with LDE resulted in lower 
populations of cecal and colonic (P < 0.05) 
Enterobacterium, cecal (P < 0.05) 
Bifidobacterium and cecal and colonic  
(P < 0.05, P < 0.001, respectively) 
Lactobacillus compared to control diet 
Animals offered combination diet had lower  
(P < 0.05) populations of colonic and cecal 
Enterobacterium and Lactobacillus (P < 0.01) 
compared to control diet 
No effects on animal 
performance 
Marginal differences in 
systemic immune response 
reported in animals fed 
combination diet 
[76] 
L. digitata extract 
containing laminarin 
(0.11 g/kg), and 
fucoidan (0.89 g/kg) 
Healthy, 
weanling 
piglets fed a 
nutritionally-
challenged diet 
Diet 1: 150g lactose (L)/kg 
Diet 2: 150 g/kg lactose +  
2.8 g/kg seaweed extract (SE) 
Diet 3: 250g lactose/kg 
Diet 4: 250g lactose /kg +  
2.8 g/kg SE 
The inclusion of SE decreased (P < 0.05) fecal 
E. coli counts compared to non-SWE diets 
Dietary inclusion of SE increased (P < 0.001) 
Lactobacillus counts in pigs fed high L diets 
Animals offered seaweed 
diets had higher (P < 0.01) 
average daily gain and gain 
to feed ratio (P < 0.05) 
Fecal score not affected by 
dietary inclusion of SE 
[81] 
 Mar. Drugs 2010, 8  
 
 
2058 
5.2.3. Additional benefits of prebiotics in swine husbandry 
Dietary prebiotic supplementation in pigs may reduce nitrogen excretion, which may have positive 
environmental  implications.  Prebiotics,  such  as  inulin  have  yielded  a  reduction  in  fecal  ammonia 
concentrations in pigs [86]. While limited studies have examined this effect using polysaccharides 
from algal sources, Reilly et al. [76] reported a significant reduction in ammonia concentrations in the 
colon of pigs offered diets containing either a L. hyperborea extract or an L. digitata extract. 
Boar taint is an undesirable taste or odor which can be evident when cooking or eating pork from 
non-castrated male pigs once they reach puberty. It is mainly caused by an accumulation of skatole and 
androstenone in adipose tissues. Skatole is produced by bacterial fermentation of tryptophan in the 
hindgut  of  animals  [87].  Where  slaughter  weight  is  high  and  consequentially  pigs  are  older  at 
slaughter, as is the case in North America and continental Europe, boar taint is usually controlled by 
castration. Countries like Ireland and the UK still produce entire male pigs since slaughter weight/age 
has traditionally been low in these countries. However, as slaughter weight and hence age at slaughter 
is increasing in Ireland and the UK and there is European pressure to ban the practice of castration, 
alternative nutritional means of mitigating against boar taint are being investigated. Lanthier et al. [88] 
demonstrated that animals offered a diet containing inulin had significantly reduced plasma, cecal and 
fat skatole concentrations compared to animals offered a control diet. The authors suggest that this is 
possibly  due  to  a  reduction  in  hindgut  proteolytic  bacteria  in  favor  of  carbohydrate-fermenting 
bacteria. In addition, Byrne et al. [89] demonstrated that feeding pigs chicory root, a rich source of 
inulin, resulted in a significant reduction in boar taint sensory characteristics and reduced blood and 
back fat concentrations to below detectable levels. To the best of our knowledge, no studies have been 
conducted to date to assess the effects of marine polysaccharides on skatole or adrostenone levels in pigs. 
6. Conclusions 
Seaweed grows in abundance in coastal areas and may be a source of compounds which could be 
exploited for novel functional ingredients for human and animal health applications. This review has 
examined the evidence from both in vitro and in vivo experiments and found that seaweed-derived 
polysaccharides  may  have  prebiotic  activity.  While  a  substantial  amount  of  research  has  been 
conducted to date on animals, no studies have been conducted in human subjects to date. Results from 
in vivo studies using laboratory animals and domestic pigs are promising. However, it is difficult to 
reach consensus on the benefits because of the conflicting results obtained in different studies. This is 
most likely due to a number of factors such as, experimental conditions, intra-laboratory variations in 
age and physiology of the animals studied, variations in the type, purity and dose of seaweed extracts 
fed, differences in the concentration of active compounds within seaweed extracts and differences in 
dietary  inclusion  of  other  feed  ingredients. In  addition  to  these  factors,  seasonal  variations  in  the 
composition of seaweed polysaccharides also require consideration when feeding intact seaweed meal. 
Future work in the area of seaweed-derived prebiotics should aim to examine the effects of purified 
seaweed polysaccharides on gut morphology and intestinal microbiota in parallel with well-established 
prebiotics, such as FOS or inulin. Furthermore, the role of seaweed prebiotics in animal husbandry Mar. Drugs 2010, 8  
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may go beyond that of health applications with potential for improvement of environmental pollution 
and meat quality.  
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